Cell type (Sample na) | CpGs at BF (Percent specific to this cell type) | Highly specific among BF (Percent highly specific)b | FDR 5% (Percent specific to this cell type) | BF replicatedc | Replicated highly cell-type-specificb |
---|---|---|---|---|---|
B cell (CD19+) (NS = 69, SM = 64)c | 111 (82.0%) | 80 (72.1%) | 3096 (93.4%) | 62 (56%) | 36 (45%) |
Granulocyte (CD15+) (NS = 67, SM = 63) | 96 (42.7%) | 26 (27.1%) | 986 (74.2%) | 84 (88%) | 16 (62%) |
Monocyte (CD14+) (NS = 71, SM = 62) | 83 (33.7%) | 12 (14.5%) | 501 (54.1%) | 78 (94%) | 10 (83%) |
Natural killer cell (CD56+) (NS = 68, SM = 58) | 19 (36.8%) | 5 (26.3%) | 482 (78.8%) | 17 (90%) | 4 (80%) |
CD4T cell (CD4+) (NS = 67, SM = 60) | 12 (66.7%) | 5 (41.7%) | 45 (62.2%) | 12 (100%) | 5 (100%) |
CD8T cell (CD8+) (NS = 68, SM = 60) | 5 (20.0%) | 1 (20%) | 10 (30.0%) | 4 (80%) | 0 (0%) |
All cell types | 238 (73.9%) | 129 (54.2%) | 4655 (93.5%) | 171 (72%) | 71 (55%) |